Global Brentuximub Vedoti Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Brentuximub Vedoti Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).
Brentuximub Vedoti report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Brentuximub Vedoti market is projected to reach US$ 2353.6 million in 2029, increasing from US$ 1481 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Hospital and Drugs Store are the major drivers for the industry.
The Adcetris market is driven by the increasing prevalence of CD30-positive lymphomas, such as Hodgkin lymphoma and anaplastic large cell lymphoma. Adcetris, containing brentuximab vedotin, is an antibody-drug conjugate that specifically targets CD30-expressing cells, offering a highly targeted and effective treatment option for these lymphomas. The drug's approval and positive clinical outcomes have led to its growing adoption in lymphoma management. However, challenges include the high cost of the medication, potential side effects, and the need for continuous research to optimize treatment regimens and expand its use in other CD30-positive malignancies. Addressing these challenges through affordability measures, ongoing research, and patient access initiatives will be crucial for the sustained growth of the Adcetris market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Brentuximub Vedoti market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Seagen
Takada
Segment by Type
Podwer
Liquid
Hospital
Drugs Store
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Brentuximub Vedoti market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Brentuximub Vedoti, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Brentuximub Vedoti industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Brentuximub Vedoti in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Brentuximub Vedoti introduction, etc. Brentuximub Vedoti Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Brentuximub Vedoti market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Brentuximub Vedoti report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Brentuximub Vedoti market is projected to reach US$ 2353.6 million in 2029, increasing from US$ 1481 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Hospital and Drugs Store are the major drivers for the industry.
The Adcetris market is driven by the increasing prevalence of CD30-positive lymphomas, such as Hodgkin lymphoma and anaplastic large cell lymphoma. Adcetris, containing brentuximab vedotin, is an antibody-drug conjugate that specifically targets CD30-expressing cells, offering a highly targeted and effective treatment option for these lymphomas. The drug's approval and positive clinical outcomes have led to its growing adoption in lymphoma management. However, challenges include the high cost of the medication, potential side effects, and the need for continuous research to optimize treatment regimens and expand its use in other CD30-positive malignancies. Addressing these challenges through affordability measures, ongoing research, and patient access initiatives will be crucial for the sustained growth of the Adcetris market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Brentuximub Vedoti market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Seagen
Takada
Segment by Type
Podwer
Liquid
Segment by Application
Hospital
Drugs Store
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Brentuximub Vedoti market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Brentuximub Vedoti, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Brentuximub Vedoti industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Brentuximub Vedoti in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Brentuximub Vedoti introduction, etc. Brentuximub Vedoti Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Brentuximub Vedoti market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices